Furthermore, TRPV4 has been recognized as a potentially valuable therapeutic target for joint diseases (52, 53); therefore, a better understanding of how TRPV4 functions in skeletal tissue development may be critical for informing therapies targeting TRPV4 mutation–associated disease or skeletal regeneration in the near future. This evidence concerns the gene TRPV4 and arthropathy.